女性甲状腺癌幸存者的不孕与妊娠率:基于以色列医疗行政数据的回顾性队列研究
该回顾性队列研究纳入2000-2020年在以色列某健康管理机构确诊的40岁及以下女性甲状腺癌患者1164例及健康对照5030例,随访中位10年。甲状腺癌组不孕率高于对照组(23.9% vs 20.4%,p=0.008),但妊娠率相当(46.9% vs 47.7%,p=0.625),且甲状腺癌组首次妊娠时间更长(37 vs 31个月,p<0.001)。
要点
- 甲状腺癌组不孕率23.9%,高于对照组的20.4%(p=0.008)。
- 甲状腺癌组与对照组妊娠率相当(46.9% vs 47.7%,p=0.625)。
- 甲状腺癌组诊断后首次妊娠时间中位37个月,长于对照组的31个月(p<0.001)。
核心结论
- 研究为甲状腺癌治疗后女性的生殖特征提供了令人安心的证据,甲状腺癌幸存者妊娠率与对照组相当。
- 但甲状腺癌组不孕率更高且受孕时间更长,这些发现在接受单次或重复放射性碘治疗(RAI)的女性中一致。
研究设计与样本
- 回顾性队列研究,利用以色列某健康管理机构的综合计算机化数据库,筛选2000-2020年确诊甲状腺癌且年龄≤40岁的所有女性患者。
- 队列纳入1164例甲状腺癌患者(诊断时中位年龄31.6岁,四分位距[IQR]:26.7-35.4)和5030例健康年龄匹配对照,随访中位10年(IQR:5.0-15.0)。
- 不孕率基于患者档案中记录的诊断或购买生育药物判定,并与健康年龄匹配对照比较。
主要发现
- 甲状腺癌组不孕率为23.9%,对照组为20.4%(p=0.008)。
- 全队列诊断后/参照日期后妊娠率在甲状腺癌组与对照组间相当(46.9% vs 47.7%,p=0.625),且在所有年龄四分位组中均相当。
- 甲状腺癌组诊断后/参照日期后首次妊娠的中位时间长于对照组(37 vs 31个月,p<0.001)。
- 在甲状腺癌组内,接受重复放射性碘治疗者(n=611,52.5%)与未接受者不孕率和妊娠率相当。
- 接受重复放射性碘治疗者诊断后首次妊娠时间更长(中位45 vs 29个月,p=0.020)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid cancer (TC) is one of the most common carcinomas in young women. Concerns have been raised regarding the impact of the disease and its treatment on reproductive function. The aim of the study was to investigate the association of TC diagnosis and radioactive iodine (RAI) treatment on infertility and pregnancy rates in women. Methods: The comprehensive computerized database of a health management organization in Israel was screened for all female patients who were diagnosed with TC at age ≤40 years in 2000-2020. Rates of infertility (based on a documented diagnosis or purchase of fertility medications in the patient files) and pregnancy were compared with healthy age-matched controls. Results: The cohort included 1164 patients with TC (median age at diagnosis 31.6 years; interquartile range [IQR]: 26.7-35.4) and 5030 controls, followed for a median period of 10 years (IQR: 5.0-15.0). The infertility rate was higher in the TC group than in the control group (23.9% vs. 20.4%, p = 0.008). Still, the postdiagnosis/referent date pregnancy rates were comparable in the whole cohort (46.9/47.7%, p = 0.625) and across all age quartiles. The median time to the first pregnancy postdiagnosis/referent date was longer in TC patients than in controls (37 vs. 31 months, p < 0.001). Within the TC group, women who received repeated radioactive iodine treatment (n = 611, 52.5%) had comparable rates of infertility and pregnancy as those who did not. However, their time to the first postdiagnosis pregnancy was longer (median 45 vs. 29 months, p = 0.020). Conclusions: Our study provides reassuring evidence about the reproductive characteristics of women treated for TC. Pregnancy rates in TC survivors were comparable with controls. However, a higher infertility rate and a longer time to conceive were observed in the TC group compared with the control group. These findings were consistent in women who received single or repeated RAI treatments.
引用
- Hirsch D, Yackobovitch-Gavan M, Lazar L, et al. Infertility and Pregnancy Rates in Female Thyroid Cancer Survivors: A Retrospective Cohort Study Using Health Care Administrative Data from Israel. Thyroid. 2023. PMID: 36785948. doi:10.1089/thy.2022.0501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。